Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Salt tablets
DIETARY_SUPPLEMENT
2 trials
Sponsors
National Cancer Institute (NCI)
, National Aeronautics and Space Administration (NASA)
Conditions
Glioblastoma
Gliosarcoma
Healthy
Newly Diagnosed
Phase 1
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
Active, not recruiting
NCT04216329
National Cancer Institute (NCI)
Glioblastoma, Gliosarcoma, Newly Diagnosed
Start: 2020-07-07
End: 2028-07-30
Updated: 2026-01-23
Unknown Phase
Fluid Loading Countermeasures
NCT06467812
National Aeronautics and Space Administration (NASA)
Healthy
Start: 2022-04-01
End: 2024-10-31
Target: 15
Updated: 2024-07-10